Format
Sort by
Items per page

Send to

Choose Destination

Best matches for hla-b schizophrenia:

Search results

Items: 1 to 20 of 51

1.

HLA typing using genome wide data reveals susceptibility types for infections in a psychiatric disease enriched sample.

Parks S, Avramopoulos D, Mulle J, McGrath J, Wang R, Goes FS, Conneely K, Ruczinski I, Yolken R, Pulver AE, Pearce BD.

Brain Behav Immun. 2018 May;70:203-213. doi: 10.1016/j.bbi.2018.03.001. Epub 2018 Mar 21.

PMID:
29574260
2.

New findings in pharmacogenetics of schizophrenia.

Zai CC, Tiwari AK, Zai GC, Maes MS, Kennedy JL.

Curr Opin Psychiatry. 2018 May;31(3):200-212. doi: 10.1097/YCO.0000000000000417.

PMID:
29528898
3.

Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.

Girardin FR, Poncet A, Perrier A, Vernaz N, Pletscher M, F Samer C, Lieberman JA, Villard J.

Pharmacogenomics J. 2018 Jan 3. doi: 10.1038/s41397-017-0004-2. [Epub ahead of print]

PMID:
29298994
4.

Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction data.

Malavia TA, Chaparala S, Wood J, Chowdari K, Prasad KM, McClain L, Jegga AG, Ganapathiraju MK, Nimgaonkar VL.

NPJ Schizophr. 2017 Feb 24;3:11. doi: 10.1038/s41537-017-0010-z. eCollection 2017.

5.

Replication of genome-wide association study (GWAS) susceptibility loci in a Latino bipolar disorder cohort.

Gonzalez S, Gupta J, Villa E, Mallawaarachchi I, Rodriguez M, Ramirez M, Zavala J, Armas R, Dassori A, Contreras J, Flores D, Jerez A, Ontiveros A, Nicolini H, Escamilla M.

Bipolar Disord. 2016 Sep;18(6):520-527. doi: 10.1111/bdi.12438.

6.

Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese Population.

Saito T, Ikeda M, Mushiroda T, Ozeki T, Kondo K, Shimasaki A, Kawase K, Hashimoto S, Yamamori H, Yasuda Y, Fujimoto M, Ohi K, Takeda M, Kamatani Y, Numata S, Ohmori T, Ueno S, Makinodan M, Nishihata Y, Kubota M, Kimura T, Kanahara N, Hashimoto N, Fujita K, Nemoto K, Fukao T, Suwa T, Noda T, Yada Y, Takaki M, Kida N, Otsuru T, Murakami M, Takahashi A, Kubo M, Hashimoto R, Iwata N.

Biol Psychiatry. 2016 Oct 15;80(8):636-42. doi: 10.1016/j.biopsych.2015.12.006. Epub 2016 Feb 11.

7.

Expression of immune genes on chromosome 6p21.3-22.1 in schizophrenia.

Sinkus ML, Adams CE, Logel J, Freedman R, Leonard S.

Brain Behav Immun. 2013 Aug;32:51-62. doi: 10.1016/j.bbi.2013.01.087. Epub 2013 Feb 8.

8.

Non-random mating, parent-of-origin, and maternal-fetal incompatibility effects in schizophrenia.

Kim Y, Ripke S, Kirov G, Sklar P, Purcell SM, Owen MJ, O'Donovan MC, Sullivan PF.

Schizophr Res. 2013 Jan;143(1):11-7. doi: 10.1016/j.schres.2012.11.002. Epub 2012 Nov 21.

9.

Carbamazepine-induced hypersensitivity syndrome in chronic schizophrenia.

Pan CW, Yu CH, Liao DL.

Gen Hosp Psychiatry. 2013 Sep-Oct;35(5):575.e9-10. doi: 10.1016/j.genhosppsych.2012.08.004. Epub 2012 Nov 13.

PMID:
23153842
10.

Immunomodulation in schizophrenia: A study among the Indian schizophrenia patients of Siliguri, West Bengal.

Singh B, Bera NK, Nayak CR, Chaudhuri TK.

Asian J Psychiatr. 2011 Dec;4(4):277-83. doi: 10.1016/j.ajp.2011.08.002. Epub 2011 Oct 12.

PMID:
23051162
11.

Detection of intergenerational genetic effects with application to HLA-B matching as a risk factor for schizophrenia.

Childs EJ, Sobel EM, Palmer CG, Sinsheimer JS.

Hum Hered. 2011;72(3):161-72. doi: 10.1159/000332051. Epub 2011 Oct 15.

12.

Study of HLA Class I gene in Indian schizophrenic patients of Siliguri, West Bengal.

Singh B, Bera NK, De S, Nayak C, Chaudhuri TK.

Psychiatry Res. 2011 Sep 30;189(2):215-9. doi: 10.1016/j.psychres.2011.03.010. Epub 2011 Apr 2.

PMID:
21459456
13.

Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia.

Palmer CG.

J Biomed Biotechnol. 2010;2010:576318. doi: 10.1155/2010/576318. Epub 2010 Apr 6. Review.

14.

Analysis of the role of human leukocyte antigen class-I genes to understand the etiopathology of schizophrenia.

Singh B, Banerjee S, Bera NK, Nayak CR, Chaudhuri TK.

Indian J Psychiatry. 2008 Jul;50(3):166-70. doi: 10.4103/0019-5545.43625.

15.
16.

HLA-B maternal-fetal genotype matching increases risk of schizophrenia.

Palmer CG, Hsieh HJ, Reed EF, Lonnqvist J, Peltonen L, Woodward JA, Sinsheimer JS.

Am J Hum Genet. 2006 Oct;79(4):710-5. Epub 2006 Aug 15.

17.

The association of the HLA in patients with schizophrenia, schizoaffective disorder, and in their biological relatives.

Nunes SO, Borelli SD, Matsuo T, Watanabe MA, Itano EN.

Schizophr Res. 2005 Jul 15;76(2-3):195-8.

PMID:
15949652
18.

The DNA sequence and analysis of human chromosome 6.

Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S.

Nature. 2003 Oct 23;425(6960):805-11.

PMID:
14574404
19.

Significant frequency deviation of the class I polymorphism HLA-A10 in schizophrenic patients.

Laumbacher B, Müller N, Bondy B, Schlesinger B, Gu S, Fellerhoff B, Wank R.

J Med Genet. 2003 Mar;40(3):217-9. No abstract available.

20.

HLA class I distribution in Japanese patients with schizophrenia.

Matsumoto S, Sasaki T, Imamura A, Matsuo K, Kayashima T, Hashida A, Ono S, Tsujita T, Matsumoto S, Nakane Y, Tokunaga K, Okazaki Y.

Am J Med Genet. 2002 Jan 8;114(1):42-5.

PMID:
11840504

Supplemental Content

Loading ...
Support Center